Veru Inc.
US ˙ NasdaqCM ˙ US92536C1036

Introduction

This page provides a comprehensive analysis of the known insider trading history of David R Bethune. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David R Bethune has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:VERU / Veru Inc. Director 0
US:CBM / Cambrex Corp. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David R Bethune. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases VERU / Veru Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in VERU / Veru Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-05-15 FHCO BETHUNE DAVID R 10,000 1.0305 10,000 1.0305 10,305 15
2017-05-12 FHCO BETHUNE DAVID R 10,000 1.0299 10,000 1.0299 10,299
2017-05-11 FHCO BETHUNE DAVID R 10,000 1.0278 10,000 1.0278 10,278
2016-12-15 FHCO BETHUNE DAVID R 200 1.0590 200 1.0590 212
2016-05-20 FHCO BETHUNE DAVID R 100 1.2600 100 1.2600 126
2013-12-18 FHCO BETHUNE DAVID R 4,000 8.0718 4,000 8.0718 32,287

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VERU / Veru Inc. Insider Trades
Insider Sales VERU / Veru Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in VERU / Veru Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VERU / Veru Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David R Bethune as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-11-01 2018-10-31 4 VERU VERU INC.
Restricted Stock Units
M - Exercise -140,000 0 -100.00
2018-11-01 2018-10-31 4 VERU VERU INC.
Common Stock
M - Exercise 140,000 575,982 32.11
2018-05-04 2018-05-02 4 VERU VERU INC.
Common Stock Option
A - Award 50,000 50,000
2017-08-04 2017-08-02 4 FHCO VERU INC.
Common Stock Option
A - Award 50,000 50,000
2017-05-17 2017-05-15 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
P - Purchase 10,000 435,982 2.35 1.03 10,305 449,279
2017-05-15 2017-05-12 4 FHCO FEMALE HEALTH CO
Common Stock, par value $0.01 per share
P - Purchase 10,000 425,982 2.40 1.03 10,299 438,719
2017-05-15 2017-05-11 4 FHCO FEMALE HEALTH CO
Common Stock, par value $0.01 per share
P - Purchase 10,000 415,982 2.46 1.03 10,278 427,546
2016-12-15 2016-12-15 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
P - Purchase 200 405,982 0.05 1.06 212 429,935
2016-11-02 2016-10-31 4 FHCO FEMALE HEALTH CO
Restricted Stock Units
A - Award 140,000 420,000 50.00
2016-11-02 2016-10-31 4 FHCO FEMALE HEALTH CO
Stock Appreciation Rights
A - Award 140,000 420,000 50.00
2016-11-02 2016-10-31 4 FHCO FEMALE HEALTH CO
Common Stock Option
A - Award 140,000 140,000 0.95 133,000 133,000
2016-11-02 2016-10-31 4 FHCO FEMALE HEALTH CO
Right to Receive Common Stock
M - Exercise 16,667 0 -100.00
2016-11-02 2016-10-31 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
M - Exercise 16,667 405,782 4.28
2016-11-02 2016-10-31 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
A - Award 140,000 389,115 56.20
2016-09-09 2016-08-27 4 FHCO FEMALE HEALTH CO
Right to Receive Common Stock
M - Exercise 8,333 0 -100.00
2016-09-09 2016-08-27 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
D - Sale to Issuer -8,333 249,115 -3.24 1.32 -11,000 328,832
2016-09-09 2016-08-27 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
M - Exercise 8,333 257,448 3.35
2016-05-23 2016-05-20 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
P - Purchase 100 249,115 0.04 1.26 126 313,885
2015-08-28 2015-08-27 4 FHCO FEMALE HEALTH CO
Right to Receive Common Stock
A - Award 25,000 25,000
2015-08-28 2015-08-27 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
A - Award 50,000 249,015 25.12
2013-12-20 2013-12-18 4/A FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
P - Purchase 4,000 199,015 2.05 8.07 32,287 1,606,409
2013-12-19 2013-12-18 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
P - Purchase 1,000 199,015 0.51 8.16 8,160 1,623,962
2013-12-19 2013-12-17 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
P - Purchase 3,000 198,015 1.54 8.04 24,120 1,592,041
2013-12-16 2013-12-12 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
A - Award 14,382 195,015 7.96
2013-05-10 2013-05-08 4 FHCO FEMALE HEALTH CO
Common Stock Option
M - Exercise -6,250 0 -100.00
2013-05-10 2013-05-08 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
F - Taxes -3,032 180,633 -1.65 8.08 -24,499 1,459,515
2013-05-10 2013-05-08 4 FHCO FEMALE HEALTH CO
Common Stock, par value $.01 per share
M - Exercise 6,250 183,665 3.52 3.92 24,500 719,967
2012-04-26 2012-04-25 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -2,000 0 -100.00
2012-04-26 2012-04-25 4 CBM CAMBREX CORP
Common Stock
M - Exercise 2,000 21,116 10.46 4.14 8,290 87,526
2005-06-03 3 CBM CAMBREX CORP
Common Stock
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)